News & Events

March 27, 2019

“Pencil Tap Feeling” Effectively Treats Young Woman’s Depression

A student graduating from Northern Arizona University had a high mountain to climb before graduation....

April 22, 2019

Massachusetts Expands Use of Deep TMS with Woburn Clinic

Achieve TMS East expands to its now 13th location in Woburn, Massachusetts, with a well-attended ribbon...

May 6, 2019

BrainsWays Deep TMS expands to Milwaukee Area

New Frontier’s Psychiatric & TMS is now the first mental health clinic in Milwaukee to offer...

May 21, 2019

Telegram.com Highlights Deep TMS for OCD Treatment

Through modern day, therapies and medication to treat OCD have been extremely limited. Now, BrainsWay’s...

May 27, 2019

Inside Edition: TMS Helmet Was the Missing Puzzle Piece for One Young Patient

From teenager to young adult studying at NorthEastern University, countless courses of medication were...

May 22, 2019

BrainsWay Announces its Multicenter Smoking Cessation Study Has Reached Target Enrollment

More than 260 participants have been enrolled to the study

March 5, 2019

BrainsWay Announces New Clinical Support Program for Physicians Treating Obsessive-Compulsive Disorder: – “BrainsWay OCD Launchpad to Success”

Program supports physicians in successfully implementing OCD Deep TMS treatment, through in-depth clinical...

March 4, 2019

BrainsWay Expands Intellectual Property Position by Obtaining Rights to Multi-Channel Transcranial Magnetic Stimulation Patent Portfolio

Acquires Multi-Channel TMS Patent Portfolio from TMS Innovations. Enters into an Exclusive Option Agreement...

February 20, 2019

BrainsWay Expands its Deep TMS Commercial Footprint into Asia Pacific

Enters into an Agreement to Distribute its Deep Transcranial Magnetic Stimulation System in South Korea.

January 29, 2019

BrainsWay Receives PMDA Approval in Japan of Deep Transcranial Magnetic Stimulation System for Treatment of Major Depressive Disorder

Approval allows BrainsWay’s Deep TMS System to be marketed throughout Japan.

October 17, 2018

BrainsWay to Showcase Deep Transcranial Magnetic Stimulation System for the Treatment of Obsessive-Compulsive Disorder at the 2018 Annual Psych Congress

Showcase represents the public debut of BrainsWay’s Deep TMS system for OCD Healthcare providers will...

June 7, 2018

BrainsWay and Cohen Veterans Bioscience Announce Biomarker Research Collaboration in Post Traumatic Stress Disorder

Unique Biomarkers Sought to Enable Personalized Medicine Approach for Treatment of Post Traumatic Stress...

April 17, 2019

BrainsWay Ltd. Announces Pricing of Initial Public Offering of 2.5 Million American Depositary Shares

JERUSALEM, Israel, April 16, 2019 – BrainsWay Ltd. (NASDAQ: BWAY and TASE:BRIN) (“BrainsWay”)...

March 26, 2019

BrainsWay Reports Financial Results for Fourth Quarter and Full-Year 2018

Full-Year 2018 revenues of $16.4 million increased 47% over full-year 2017 Fourth quarter revenues of...

February 19, 2019

BrainsWay Receives FDA 510(k) Clearance for Use of its Next-Generation Stimulator for the Treatment of Obsessive Compulsive Disorder

Advances BrainsWay’s Leadership in Deep Transcranial Magnetic Stimulation (Deep TMS)